- Home
- IMRN vs FEBO Comparison
IMRN vs FEBO Comparison
Compare IMRN & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- FEBO
- Stock Information
- Founded
- IMRN 1994
- FEBO 1993
- Country
- IMRN Australia
- FEBO Hong Kong
- Employees
- IMRN N/A
- FEBO N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- FEBO
- Sector
- IMRN Health Care
- FEBO
- Exchange
- IMRN Nasdaq
- FEBO Nasdaq
- Market Cap
- IMRN 14.4M
- FEBO 8.3M
- IPO Year
- IMRN N/A
- FEBO 2023
- Fundamental
- Price
- IMRN $1.90
- FEBO $0.78
- Analyst Decision
- IMRN
- FEBO
- Analyst Count
- IMRN 0
- FEBO 0
- Target Price
- IMRN N/A
- FEBO N/A
- AVG Volume (30 Days)
- IMRN 93.9K
- FEBO 20.2K
- Earning Date
- IMRN 08-29-2025
- FEBO 11-11-2025
- Dividend Yield
- IMRN N/A
- FEBO N/A
- EPS Growth
- IMRN N/A
- FEBO N/A
- EPS
- IMRN N/A
- FEBO N/A
- Revenue
- IMRN $4,777,422.00
- FEBO $17,110,653.00
- Revenue This Year
- IMRN N/A
- FEBO N/A
- Revenue Next Year
- IMRN N/A
- FEBO N/A
- P/E Ratio
- IMRN N/A
- FEBO N/A
- Revenue Growth
- IMRN 48.63
- FEBO 11.58
- 52 Week Low
- IMRN $1.50
- FEBO $0.61
- 52 Week High
- IMRN $2.48
- FEBO $3.71
- Technical
- Relative Strength Index (RSI)
- IMRN 37.34
- FEBO 52.98
- Support Level
- IMRN $2.09
- FEBO $0.75
- Resistance Level
- IMRN $2.24
- FEBO $0.82
- Average True Range (ATR)
- IMRN 0.13
- FEBO 0.05
- MACD
- IMRN -0.04
- FEBO 0.01
- Stochastic Oscillator
- IMRN 17.24
- FEBO 62.63
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.